View in EDS

Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis.

Saved in:
Bibliographic Details
Title: Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis.
Authors: Stuart WH; Peachtree Neurological Clinic, 3200 Downwood Circle, Suite 550, Atlanta, Georgia 30327, USA. whstuart@aol.com, Cohan S, Richert JR, Achiron A
Source: Neurology [Neurology] 2004 Dec 14; Vol. 63 (11 Suppl 5), pp. S19-27.
Publication Type: Journal Article; Review
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 15596732
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stuart+WH%22">Stuart WH</searchLink>; Peachtree Neurological Clinic, 3200 Downwood Circle, Suite 550, Atlanta, Georgia 30327, USA. whstuart@aol.com<br /><searchLink fieldCode="AU" term="%22Cohan+S%22">Cohan S</searchLink><br /><searchLink fieldCode="AU" term="%22Richert+JR%22">Richert JR</searchLink><br /><searchLink fieldCode="AU" term="%22Achiron+A%22">Achiron A</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220401060%22">Neurology</searchLink> [Neurology] 2004 Dec 14; Vol. 63 (11 Suppl 5), pp. S19-27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0401060 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1526-632X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200283878%22">00283878 </searchLink><i>NLM ISO Abbreviation: </i>Neurology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=15596732
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1212/wnl.63.11_suppl_5.s19
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: S19
    Titles:
      – TitleFull: Selecting a disease-modifying agent as platform therapy in the long-term management of multiple sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stuart WH
      – PersonEntity:
          Name:
            NameFull: Cohan S
      – PersonEntity:
          Name:
            NameFull: Richert JR
      – PersonEntity:
          Name:
            NameFull: Achiron A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 12
              Text: 2004 Dec 14
              Type: published
              Y: 2004
          Identifiers:
            – Type: issn-electronic
              Value: 1526-632X
          Numbering:
            – Type: volume
              Value: 63
            – Type: issue
              Value: 11 Suppl 5
          Titles:
            – TitleFull: Neurology
              Type: main
ResultId 1